TENAX THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
TENAX THERAPEUTICS, INC. (TENX) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 20.47 thousand shares for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2018-05-15
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2018-03-31 was 20.47K shares, a 78.92% decline year-over-year.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2017-12-31 was -92.31K shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2017-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2017-06-30 was 54.00 shares, a 28.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2017 was 4.87K shares, a 44127.27% increase from fiscal 2016.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2016 was 11.00 shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2015 was 15.05K shares, a 66.44% decline from fiscal 2014.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2014 was 44.87K shares, a 761.81% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 8 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-03-31 | 20.47K shares 10-Q · filed 2018-05-15 | -71.84K shares derived: sum of 2 quarters · filed 2018-05-15 | -71.84K shares derived: sum of 3 quarters · filed 2018-05-15 | -71.78K shares derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2017-12-31 | -92.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -92.31K shares derived: sum of 2 quarters · filed 2018-04-02 | -92.26K shares derived: sum of 3 quarters · filed 2018-04-02 | 4.87K shares 10-K · filed 2018-04-02 | ||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 54.00 shares derived: sum of 2 quarters · filed 2017-11-09 | 97.17K shares 10-Q · filed 2017-11-09 | 96.97K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-06-30 | 54.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 97.17K shares 10-Q · filed 2017-08-09 | 96.97K shares derived: sum of 3 quarters · filed 2018-04-02 | 97.03K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-03-31 | 97.12K shares 10-Q · filed 2017-05-10 | 96.92K shares derived: sum of 2 quarters · filed 2018-04-02 | 96.98K shares derived: sum of 3 quarters · filed 2018-04-02 | 97.06K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2016-12-31 | -206.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -140.00 shares derived: sum of 2 quarters · filed 2018-04-02 | -65.00 shares derived: sum of 3 quarters · filed 2018-04-02 | 11.00 shares 10-K · filed 2018-04-02 | 217.00 shares 10-K · filed 2017-03-16 | |
| 2016-09-30 | 66.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 141.00 shares derived: sum of 2 quarters · filed 2016-11-09 | 217.00 shares 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | 75.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 151.00 shares 10-Q · filed 2016-08-09 | ||||
| 2016-03-31 | 76.00 shares 10-Q · filed 2016-05-10 | |||||
| 2015-12-31 | 132.00 shares 10-K · filed 2017-03-16 | |||||
| 2015-10-31 | -66.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | -132.00 shares 10-Q · filed 2015-12-10 | 29.90K shares derived: sum of 3 quarters · filed 2017-03-16 | 29.82K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-07-31 | -66.00 shares 10-Q · filed 2015-09-09 | 29.96K shares derived: sum of 2 quarters · filed 2017-03-16 | 29.89K shares derived: sum of 3 quarters · filed 2017-03-16 | 157.00 shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-04-30 | 30.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 29.95K shares derived: sum of 2 quarters · filed 2017-03-16 | 223.00 shares derived: sum of 3 quarters · filed 2017-03-16 | 15.05K shares 10-K · filed 2017-03-16 | -15.05K shares 10-K · filed 2015-07-14 | |
| 2015-01-31 | -76.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -29.80K shares derived: sum of 2 quarters · filed 2015-03-17 | -14.97K shares 10-Q · filed 2015-03-17 | 74.69K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-10-31 | -29.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -14.90K shares 10-Q · filed 2014-12-15 | 74.77K shares derived: sum of 3 quarters · filed 2017-03-16 | 74.70K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-07-31 | 14.83K shares 10-Q · filed 2014-09-15 | 104.50K shares derived: sum of 2 quarters · filed 2017-03-16 | 104.43K shares derived: sum of 3 quarters · filed 2017-03-16 | 60.05K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-04-30 | 89.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 89.60K shares derived: sum of 2 quarters · filed 2017-03-16 | 45.22K shares derived: sum of 3 quarters · filed 2017-03-16 | 44.87K shares 10-K · filed 2017-03-16 | -44.87K shares 10-K · filed 2014-07-29 | |
| 2014-01-31 | -63.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | -44.45K shares derived: sum of 2 quarters · filed 2014-03-17 | -44.80K shares 10-Q · filed 2014-03-17 | -26.15K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-10-31 | -44.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-17 | -44.73K shares 10-Q · filed 2013-12-17 | -26.09K shares derived: sum of 3 quarters · filed 2016-03-14 | -27.34K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-07-31 | -351.00 shares 10-Q · filed 2013-09-17 | 18.30K shares derived: sum of 2 quarters · filed 2016-03-14 | 17.05K shares derived: sum of 3 quarters · filed 2016-03-14 | 6.34K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-04-30 | 18.65K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | 17.40K shares derived: sum of 2 quarters · filed 2016-03-14 | 6.69K shares derived: sum of 3 quarters · filed 2016-03-14 | 5.21K shares 10-KT · filed 2016-03-14 | -5.21K shares 10-K · filed 2013-06-26 | |
| 2013-01-31 | -1.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | -11.96K shares derived: sum of 2 quarters · filed 2013-03-18 | -13.44K shares 10-Q · filed 2013-03-18 | |||
| 2012-10-31 | -10.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | -12.19K shares 10-Q · filed 2012-12-14 | ||||
| 2012-07-31 | -1.48K shares 10-Q · filed 2012-09-19 | |||||
| 2012-04-30 | -7.07K shares 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |